The article discusses the previous hype around the therapeutic potential of psychedelics such as LSD, ayahuasca, and magic mushrooms, which were heralded by some media outlets, including the New York Times, as revolutionary treatments for mental health issues like anxiety and depression. It points out that while early studies reported promising results, they often lacked proper controls and sufficient sample sizes, raising questions about their scientific rigor.

The author, Christian Weber, emphasizes that disproportionate excitement around these substances overlooked critical aspects of study design and methodology, leading to inflated expectations about their efficacy. The commentary asserts that while scientific exploration in psychiatry is crucial, the potential for miraculous outcomes is often overstated, particularly in a field that requires more cautious and methodologically sound approaches.

The text ultimately warns against falling into the trap of uncritical acceptance of trends within the scientific community, suggesting that genuine breakthroughs in mental health treatments depend on stringent research and validation processes. It highlights the importance of grounding psychedelic research in more reliable methodologies to avoid misinterpretations that could mislead both the public and the science itself.